| Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study D Tewari, JJ Java, R Salani, DK Armstrong, M Markman, T Herzog, ... Journal of Clinical Oncology 33 (13), 1460-1466, 2015 | 307 | 2015 |
| Nodal metastasis risk in endometrioid endometrial cancer MR Milam, J Java, JL Walker, DS Metzinger, LP Parker, RL Coleman, ... Obstetrics & Gynecology 119 (2 Part 1), 286-292, 2012 | 207 | 2012 |
| Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable … PG Rose, J Java, CW Whitney, FB Stehman, R Lanciano, GM Thomas, ... Journal of Clinical Oncology 33 (19), 2136-2142, 2015 | 171 | 2015 |
| Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study LM Landrum, J Java, CA Mathews, GS Lanneau Jr, LJ Copeland, ... Gynecologic oncology 130 (1), 12-18, 2013 | 169 | 2013 |
| The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study CC Gunderson, J Java, KN Moore, JL Walker Gynecologic oncology 133 (1), 23-27, 2014 | 159 | 2014 |
| Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study KS Tewari, JJ Java, RN Eskander, BJ Monk, RA Burger Annals of Oncology 27 (1), 114-121, 2016 | 116 | 2016 |
| Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin … PG Rose, JJ Java, CW Whitney, FB Stehman, R Lanciano, GM Thomas Gynecologic oncology 135 (2), 208-212, 2014 | 113 | 2014 |
| Survival in women with grade 1 serous ovarian carcinoma AN Fader, J Java, S Ueda, RE Bristow, DK Armstrong, MA Bookman, ... Obstetrics & Gynecology 122 (2 PART 1), 225-232, 2013 | 111 | 2013 |
| Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study JS Ferriss, JJ Java, MA Bookman, GF Fleming, BJ Monk, JL Walker, ... Gynecologic oncology 139 (1), 17-22, 2015 | 101 | 2015 |
| Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: an NRG Oncology/Gynecologic Oncology Group ancillary analysis AN Fader, J Java, M Tenney, S Ricci, CC Gunderson, SM Temkin, ... Gynecologic oncology 143 (3), 460-465, 2016 | 99 | 2016 |
| Neonatal gut and respiratory microbiota: coordinated development through time and space A Grier, A McDavid, B Wang, X Qiu, J Java, S Bandyopadhyay, H Yang, ... Microbiome 6, 1-19, 2018 | 91 | 2018 |
| Patient and physician perceptions of virtual visits for Parkinson's disease: a qualitative study JR Mammen, MJ Elson, JJ Java, CA Beck, DB Beran, KM Biglan, ... Telemedicine and e-Health 24 (4), 255-267, 2018 | 87 | 2018 |
| The prognostic significance of pre-and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study AN Fader, J Java, TC Krivak, RE Bristow, AI Tergas, MA Bookman, ... Gynecologic oncology 132 (3), 560-565, 2014 | 66 | 2014 |
| Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study EA Bishop, JJ Java, KN Moore, NM Spirtos, ML Pearl, O Zivanovic, ... American journal of obstetrics and gynecology 218 (1), 109. e1-109. e11, 2018 | 60 | 2018 |
| Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary … KN Moore, JJ Java, KN Slaughter, PG Rose, R Lanciano, PA DiSilvestro, ... Gynecologic oncology 143 (2), 294-301, 2016 | 53 | 2016 |
| Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group KS Tewari, JJ Java, TA Gatcliffe, MA Bookman, BJ Monk Gynecologic oncology 133 (3), 439-445, 2014 | 53 | 2014 |
| Static analysis for web service security-Tools & techniques for a secure development life cycle A Masood, J Java 2015 IEEE International Symposium on Technologies for Homeland Security (HST …, 2015 | 49 | 2015 |
| A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy RA Previs, KS Bevis, W Huh, T Tillmanns, L Perry, K Moore, J Chapman, ... Gynecologic oncology 132 (3), 531-536, 2014 | 40 | 2014 |
| Nomogram for predicting individual survival after recurrence of advanced-stage, high-grade ovarian carcinoma PG Rose, JJ Java, R Salani, MA Geller, AA Secord, KS Tewari, ... Obstetrics & Gynecology 133 (2), 245-254, 2019 | 36 | 2019 |
| Treatment outcomes for older women with advanced ovarian cancer: Results from a phase III clinical trial (GOG182). WP Tew, J Java, D Chi, A Menzin, JL Lovecchio, MA Bookman, ... Journal of Clinical Oncology 28 (15_suppl), 5030-5030, 2010 | 32 | 2010 |
